IMMUNE DESIGN CORP - COM (IMDZ)

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
12,887,101
Share change
+591,815
Total reported value
$87,612,793
Put/Call ratio
30%
Price per share
$6.80
Number of holders
57
Value change
+$4,982,790
Number of buys
28
Number of sells
31

Institutional Holders of IMMUNE DESIGN CORP - COM (IMDZ) as of Q1 2017

As of 31 Mar 2017, IMMUNE DESIGN CORP - COM (IMDZ) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,887,101 shares. The largest 10 holders included Versant Venture Management, LLC, ProQuest Associates IV LLC, VICTORY CAPITAL MANAGEMENT INC, BVF INC/IL, BlackRock Inc., FRANKLIN RESOURCES INC, FMR LLC, VANGUARD GROUP INC, Abingworth LLP, and Cormorant Asset Management, LLC. This page lists 57 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.